Epigral Share Price Falls 2.91 Percent After Q1 Results
- July 28, 2026
- Posted by: Kunal Singla
- Category: News
Epigral Share Price Rs 1,123.30, down 2.91 percent. Q1 net profit Rs 99.7 crore, down 37.9 percent year on year. Revenue from Operations Rs 705.4 crore, up 16.3 percent year on year.
Epigral Share Price fell 2.91 percent in trade as investors reacted to the company’s June quarter FY27 results. The stock was quoting at Rs 1,123.30, down Rs 33.70 or 2.91 percent, against a previous close of Rs 1,157.00.
Epigral’s consolidated net profit declined even as revenue grew in double digits, with the company citing fluctuations in raw material and finished goods prices, elevated freight costs and shipment delays tied to geopolitical tensions in West Asia during the quarter. Management said operating conditions have since stabilised, and the company continues to back its long term growth plans despite the near term volatility affecting the specialty chemicals sector.
Click Here – Get Free Investment Predictions
Epigral Share Price Today: Key Trading Levels
Epigral touched an intraday high of Rs 1,169.60 and an intraday low of Rs 1,116.40 during the session, opening at Rs 1,164.30 against the previous close of Rs 1,157.00.
| Metric | Value |
|---|---|
| Company | Epigral |
| CMP | Rs 1,123.30 |
| Change | Rs -33.70 (-2.91 percent) |
| Open | Rs 1,164.30 |
| Intraday High | Rs 1,169.60 |
| Intraday Low | Rs 1,116.40 |
| Previous Close | Rs 1,157.00 |
Check Live Stock Screener for More Specialty Chemical Sector Picks
Epigral Q1 FY27 Results: Key Numbers
Epigral reported a net profit of Rs 99.7 crore for the June quarter of FY27, down 37.9 percent year on year, compared to Rs 160.7 crore in the same quarter last year. Revenue from Operations came in at Rs 705.4 crore, up 16.3 percent year on year, against Rs 606.5 crore a year earlier.
EBITDA rose 9.7 percent to Rs 179.2 crore from Rs 163.4 crore a year earlier, though the EBITDA margin narrowed to 25.4 percent from 26.9 percent, reflecting the cost pressures the integrated chemical maker faced during the period.
Quarterly comparisons of this kind, measured against the same period a year earlier, help smooth out seasonal effects that can otherwise distort a single quarter’s numbers, and remain the standard yardstick analysts use when assessing Epigral’s underlying growth trajectory.
Epigral Share Price Falls as Margins Narrow Despite Revenue Growth
The board also approved entry into the epoxy resin business with a planned capacity of 1,25,000 TPA involving Rs 600 crore of capital expenditure, a forward integration move management expects to commission in the second half of FY28 alongside continued positive long term guidance.
Epigral Share Price Outlook After Q1 Results
Epigral Share Price reaction reflects how the market is weighing the quarter’s numbers against expectations. Investors tracking Epigral should watch the stock’s trend over the next few sessions, along with any management commentary from the post-results earnings call, before drawing firm conclusions about the medium-term outlook.
Quarterly result days often bring above-average trading volumes as both retail and institutional investors reposition around the fresh numbers. For Epigral Share Price specifically, the next few sessions will show whether today’s move holds, extends, or reverses once the broader market has had time to fully digest the details in the results filing and any accompanying investor presentation.
Download the Univest iOS App or Univest Android App to track Epigral share price movements live and get quarterly result alerts.
Conclusion
Epigral Share Price fell 2.91 percent to Rs 1,123.30 after the company posted a Q1 FY27 net profit of Rs 99.7 crore, down 37.9 percent year on year. Investors evaluating Epigral should review the full results and management commentary and consult a SEBI-registered investment advisor before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs
Why did Epigral Share Price move today?
Ans. Epigral Share Price fell 2.91 percent to Rs 1,123.30 after the company reported its Q1 FY27 results, with net profit of Rs 99.7 crore, down 37.9 percent year on year.
What was Epigral’s Q1 FY27 net profit?
Ans. Epigral reported a net profit of Rs 99.7 crore for the June quarter of FY27, down 37.9 percent year on year, compared to Rs 160.7 crore a year earlier.
What was the intraday range for Epigral Share Price today?
Ans. Epigral Share Price touched an intraday high of Rs 1,169.60 and an intraday low of Rs 1,116.40 during the session.
How did Epigral’s revenue perform in Q1 FY27?
Ans. Epigral’s revenue from operations came in at Rs 705.4 crore in Q1 FY27, up 16.3 percent year on year, compared to Rs 606.5 crore in the same quarter last year.
Why did Epigral’s Q1 FY27 net profit decline despite higher revenue?
Ans. Epigral’s Q1 FY27 net profit fell 37.9 percent despite 16.3 percent revenue growth due to fluctuations in raw material and finished goods prices, elevated freight costs and shipment delays linked to geopolitical tensions.
Should investors buy Epigral Share Price after the Q1 results?
Ans. Investors should evaluate Epigral’s full quarterly performance, management commentary, and valuation, and consult a SEBI-registered investment advisor before making any buy, hold, or sell decisions.
What was the previous close for Epigral Share Price before today’s results reaction?
Ans. Epigral Share Price previous close was Rs 1,157.00, against which the stock moved to Rs 1,123.30 today.
